C. Steinborn

CILANSETRON IN IRRITABLE BOWEL SYNDROME WITH DIARRHEA PREDOMINANCE (IBS-D): EFFICACY AND SAFETY IN A 3 MONTH US STUDY

S. Caras, P. Miner, D. Stanton, 2004 .

Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial.

C. Steinborn, G. Stacher-Janotta, U. Weber, 2000, British journal of clinical pharmacology.

Cilansetron shows efficacy in male and female non-constipated patients with irritable bowel syndrome in a United States study

S. Caras, E. Biesheuvel, C. Steinborn, 2001 .

CILANSETRON IMPROVES HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA PREDOMINANCE (IBS-D): 849

D. Drossman, S. Caras, K. Olden, 2004 .

Cilansetron shows efficacy in non-constipated irrirable bowel syndrome patients independent of the definition of the patient population by Rome I or Rome II

S. Caras, E. Biesheuvel, C. Steinborn, 2001 .